Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SANUWAVE Health (SNWV) EBITDA Margin (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed EBITDA Margin for 9 consecutive years, with 57.43% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 18629.0% to 57.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26.82% through Dec 2025, up 12782.0% year-over-year, with the annual reading at 26.82% for FY2025, 12782.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 57.43% at SANUWAVE Health, down from 85.96% in the prior quarter.
  • The five-year high for EBITDA Margin was 86.51% in Q2 2024, with the low at 491.45% in Q3 2023.
  • Average EBITDA Margin over 3 years is 82.62%, with a median of 65.55% recorded in 2025.
  • The sharpest move saw EBITDA Margin plummeted -14240bps in 2024, then surged 31208bps in 2025.
  • Over 3 years, EBITDA Margin stood at 13.54% in 2023, then plummeted by -1051bps to 128.86% in 2024, then surged by 145bps to 57.43% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 57.43%, 85.96%, and 5.48% for Q4 2025, Q3 2025, and Q2 2025 respectively.